FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

703682001: Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3502319012 Canagliflozin 100 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3677238017 Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
87490501000001114 Canagliflozin 100mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Is a Product containing canagliflozin false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has active ingredient Canagliflozin false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has active ingredient Canagliflozin false Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has presentation strength numerator value 100 false Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has precise active ingredient Canagliflozin true Inferred relationship Existential restriction modifier 1
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Is a Product containing canagliflozin in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Is a Product containing only canagliflozin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has active ingredient Canagliflozin false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has basis of strength substance Canagliflozin false Inferred relationship Existential restriction modifier
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Invokana 100mg tablets (Ethigen Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Invokana 100mg tablets (Pharmaram Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Canagliflozin 100mg tablets 28 tablet Has VMP False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Invokana 100mg tablets (DE Pharmaceuticals) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Invokana 100mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Invokana 100mg tablets (Janssen-Cilag Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Canagliflozin 100mg tablets 30 tablet Has VMP False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Canagliflozin 100mg tablets (Colorama Pharmaceuticals Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Canagliflozin 100mg tablets (J M McGill Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Canagliflozin 100mg tablets (Niche Pharma Ltd) Is a False Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start